{"title":"肥胖对全因死亡率的异质性影响:中国住院患者的因果森林分析","authors":"Menghui Liu, Zemeihong Xu, Lixiang He, Xingfeng Xu, Xiaojie Cai, Yue Guo, Shaozhao Zhang, Xinghao Xu, Zhenyu Xiong, Xiaodong Zhuang, Xinxue Liao","doi":"10.1111/dom.16391","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To confirm the 'obesity paradox' in hospitalized populations and examine the heterogeneous effects of obesity on all-cause mortality risk.</p><p><strong>Materials and methods: </strong>We included 5967 hospitalized patients from the Real-world Data of Cardiometabolic Protection (RED-CARPET) study (ChiCTR2000039901) in China. After 1:1 k-nearest neighbours matching, a causal forest model classified the population into four subgroups. Cox models were used to assess the association between obesity and all-cause mortality, with external validation in the Atherosclerosis Risk in Communities (ARIC) cohort.</p><p><strong>Results: </strong>During a median follow-up of 63.8 months, 919 (15.4%) deaths occurred. A U-shaped association between body mass index (BMI) and all-cause mortality was observed, illustrating the 'obesity paradox', with the highest mortality rate (18.5%) observed in the normal weight group. Furthermore, 911 participants with obesity and 911 participants with normal weight, matched for homogeneity, were categorized into four subgroups using the causal forest model. In subgroup 3 (with good renal function, well-controlled blood glucose and favourable nutritional status), patients with obesity had a higher risk of all-cause mortality compared to those with normal weight (HR, 2.12; 95% CI, 1.06-4.22; p = 0.033). No significant association was observed in the other subgroups (p > 0.05). Similar results were verified in the ARIC study cohort.</p><p><strong>Conclusions: </strong>The association between obesity and all-cause mortality is heterogeneous, as individuals with good renal function, well-controlled blood glucose and favourable nutritional status may experience a higher mortality risk. These findings emphasize the need for personalized management strategies in clinical practice to address the varying effects of obesity across different health conditions.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Heterogeneous effects of obesity on all-cause mortality: A causal forest analysis of hospitalized patients in China.\",\"authors\":\"Menghui Liu, Zemeihong Xu, Lixiang He, Xingfeng Xu, Xiaojie Cai, Yue Guo, Shaozhao Zhang, Xinghao Xu, Zhenyu Xiong, Xiaodong Zhuang, Xinxue Liao\",\"doi\":\"10.1111/dom.16391\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>To confirm the 'obesity paradox' in hospitalized populations and examine the heterogeneous effects of obesity on all-cause mortality risk.</p><p><strong>Materials and methods: </strong>We included 5967 hospitalized patients from the Real-world Data of Cardiometabolic Protection (RED-CARPET) study (ChiCTR2000039901) in China. After 1:1 k-nearest neighbours matching, a causal forest model classified the population into four subgroups. Cox models were used to assess the association between obesity and all-cause mortality, with external validation in the Atherosclerosis Risk in Communities (ARIC) cohort.</p><p><strong>Results: </strong>During a median follow-up of 63.8 months, 919 (15.4%) deaths occurred. A U-shaped association between body mass index (BMI) and all-cause mortality was observed, illustrating the 'obesity paradox', with the highest mortality rate (18.5%) observed in the normal weight group. Furthermore, 911 participants with obesity and 911 participants with normal weight, matched for homogeneity, were categorized into four subgroups using the causal forest model. In subgroup 3 (with good renal function, well-controlled blood glucose and favourable nutritional status), patients with obesity had a higher risk of all-cause mortality compared to those with normal weight (HR, 2.12; 95% CI, 1.06-4.22; p = 0.033). No significant association was observed in the other subgroups (p > 0.05). Similar results were verified in the ARIC study cohort.</p><p><strong>Conclusions: </strong>The association between obesity and all-cause mortality is heterogeneous, as individuals with good renal function, well-controlled blood glucose and favourable nutritional status may experience a higher mortality risk. These findings emphasize the need for personalized management strategies in clinical practice to address the varying effects of obesity across different health conditions.</p>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/dom.16391\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16391","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Heterogeneous effects of obesity on all-cause mortality: A causal forest analysis of hospitalized patients in China.
Aims: To confirm the 'obesity paradox' in hospitalized populations and examine the heterogeneous effects of obesity on all-cause mortality risk.
Materials and methods: We included 5967 hospitalized patients from the Real-world Data of Cardiometabolic Protection (RED-CARPET) study (ChiCTR2000039901) in China. After 1:1 k-nearest neighbours matching, a causal forest model classified the population into four subgroups. Cox models were used to assess the association between obesity and all-cause mortality, with external validation in the Atherosclerosis Risk in Communities (ARIC) cohort.
Results: During a median follow-up of 63.8 months, 919 (15.4%) deaths occurred. A U-shaped association between body mass index (BMI) and all-cause mortality was observed, illustrating the 'obesity paradox', with the highest mortality rate (18.5%) observed in the normal weight group. Furthermore, 911 participants with obesity and 911 participants with normal weight, matched for homogeneity, were categorized into four subgroups using the causal forest model. In subgroup 3 (with good renal function, well-controlled blood glucose and favourable nutritional status), patients with obesity had a higher risk of all-cause mortality compared to those with normal weight (HR, 2.12; 95% CI, 1.06-4.22; p = 0.033). No significant association was observed in the other subgroups (p > 0.05). Similar results were verified in the ARIC study cohort.
Conclusions: The association between obesity and all-cause mortality is heterogeneous, as individuals with good renal function, well-controlled blood glucose and favourable nutritional status may experience a higher mortality risk. These findings emphasize the need for personalized management strategies in clinical practice to address the varying effects of obesity across different health conditions.
期刊介绍:
Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.